DURHAM, N.C.--(BUSINESS WIRE)--bioMérieux, a world leader in the field of in vitro diagnostics, today announced the results of three surveys aimed at assessing opinions regarding bacterial sepsis in U.S. hospitals and the importance of new technologies and/or methods to solve current complexities surrounding diagnosis and treatment. The surveys were fielded during recent conferences of the American College of Chest Physicians (CHEST), the American College of Emergency Physicians (ACEP) and the Society for Critical Care Medicine (SCCM).
